Rachel Winokur leads mergers and acquisitions, strategy, and the development and operations of Healthagen‘s emerging businesses. She joined Healthagen from the Carlyle Group, a global private equity firm, where she invested in healthcare companies for Carlyle’s US Growth Equity Fund. Prior to that role, she was Vice President of Business Development and a corporate officer of Datascope, a publicly-traded medical devices company focused on cardiovascular medicine and critical care that was acquired by Mindray and Gettinge.
Keep up with Rachel:
Image credit: LinkedIn